AstraZeneca Covid vaccine row: As of April 30, 2024, over 1.7 billion doses of the Covishield vaccine has been administered in India
75% of PE-VC investments were directed towards conventional sectors such as healthcare, retail, energy, advanced manufacturing
The hospital group also claims that the ERP program improves the survival rate of the patients by approximately 2-3 per cent while enhancing patient outcomes through advanced techniques
Procter & Gamble Health on Thursday said its profit after tax declined 21 per cent year-on-year to Rs 46 crore for the third quarter ended March 2024. The company, which follows the July-June financial year, reported a profit after tax (PAT) of Rs 59 core a year ago. Its revenue from operations declined to Rs 252 crore for the period under review compared to Rs 321 crore in the year-ago period, Procter & Gamble (P&G) Health said in a regulatory filing. "The company's continued efforts to strengthen our reach and distribution with a transformed go-to-market model reflected in a one-time impact on the quarter's sales owing to the transition and optimisation of trade management and inventory," P&G Health India Managing Director Milind Thatte said. "However, we have seen sales recover in the months of March and April," he added.
The company reached a $1.1 billion settlement for CPAP machine lawsuits in US
Similar to the CoWIN portal for covid-19, the government's U-WIN platform registers and tracks routine vaccination and immunisation
Former ICMR scientist Raman Gangakhedkar said the risk is highest after the initial dose, eventually decreasing with subsequent doses
Manufactured first in 2021, the AstraZeneca vaccine, known in India as Covishield, has been facing scrutiny over the years, with many countries banning it back in 2021 itself
Many industry bodies too had become party to the case, urging the apex court to listen to their grievances as well
AstraZeneca has admitted for the first time in court documents that its Covid vaccine can cause rare side effects, marking an about-turn that may open the door for a multi-million pound legal payout
The hospital and Chennai-based NGO helped Pakistani family settle bill of more than Rs 35 lakh for the transplant
Linking deadline will from June 30 extended to 120 days, from 30 days now
The expected revenue growth in FY25 comes on the back of an estimated 14% growth in the last financial year
Three-time former Pakistan premier Nawaz Sharif will embark on Monday on a five-day personal visit to China, where he will undergo a medical checkup, according to a media report. This will be 74-year-old Sharif's first international visit after he returned to Pakistan in October last year following a four-year self-imposed exile in the UK. The Pakistan Muslim League-Nawaz (PML-N) supremo will be accompanied by Foreign Minister Ishaq Dar on his "personal visit", Geo News reported on Monday. Sharif's visit is personal and during the trip, he will undergo a medical checkup, the report said, quoting party sources. The former prime minister would also hold meetings related to the development works of the Punjab province and will also meet the owners of Chinese companies, sources said. The PML-N leader was allowed by a high court in November 2019 to go abroad on health grounds after his medical reports revealed that he needed urgent treatment. He returned to Pakistan from London in Oct
World Liver Day gives an opportunity to teach people about the risk factors for liver infection, which incorporate liquor consumption, obesity, viral hepatitis, and certain drugs
The FDA questioned Kilitch's quality system, citing concerns about its ability to ensure data accuracy and integrity for drug safety
“We just need to get our basic primary and secondary education right. We are reasonably far away from being able to produce a fit, healthy and able workforce that will allow us to become Viksit Bharat
The target of homoeopathy is to address and to give therapy the whole of an individual, including their character, way of life, hereditary predispositions, and disease history
Aster DM has fixed April 23, 2024 as the 'Record Date' for determining entitlement of the shareholders to the interim dividend for the financial year 2023-24 and special dividend
As per the WHO, in 2020, India accounted for 18 per cent of the global burden of kala-azar